Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania

ConditionsHIVPrEP
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-24
SponsorMzumbe University - Centre of Excellence in Health Monitoring and Evaluation

About this trial

Implementation study comparing standard pre-exposure prophylaxis (PrEP) services to four models of pharmacy-based PrEP access for young women aged 18-24 (YW) in Tanzania. At 9 months, all sites converge to one pharmacy-based PrEP model and are randomly allocated to one of two cost sharing models to increase the program's potential for sustainability.

Eligibility criteria

Qualifiers

Female sex;

Age 18-24 at the baseline visit;

Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania with no known plans to move;

Interested in starting PrEP;

Disqualifiers

Female sex;

Age 18-24; and

Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania.

Geographically located within one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania;

Trial design

Treatments tested in this trial

  • Pharmacy-based PrEP services
  • Distribution of HIV self-test kits

Treatment groups

2,818 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

University of California, Berkeley

Collaborator

University of California, San Francisco

Collaborator